Matches in SemOpenAlex for { <https://semopenalex.org/work/W4251648342> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4251648342 abstract "Abstract Background : Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients with HCC show reduced sensitivity to sorafenib during treatment. SIRT3, a member of the mammalian sirtuin family, is a tumor suppressor in certain tumor types. However, only few studies have investigated the effects of SIRT3 on tumor prognosis and sorafenib sensitivity in patients with HCC. Here, we aimed to investigate the correlation between SIRT3 expression and glucose metabolism and proliferation in HCC and discover effective compounds that increase endogenous SIRT3 modulation effect of sorafenib. Methods: To determine the correlation between SIRT3 and glucose related proteins, immunostaining was performed with liver cancer tissue using various antibodies. To investigate whether the expression of SIRT3 in HCC is related to the resistance to sorafenib, we treated sorafenib after the modulation of SIRT3 levels in HCC cell lines (overexpression in Huh7, knockdown in HepG2). We also employed PD0332991 to modulate the SIRT3 expression in HCC cell and conducted functional assays. Results: SIRT3 expression was downregulated in high glycolytic and proliferative HCC cells of human patients, xenograft model and HCC cell lines. Moreover, SIRT3 expression was downregulated after sorafenib treatment, resulting in reduced drug sensitivity in HCC cell lines. To enhance the anti-tumor effect of sorafenib, we employed PD0332991 (CDK4/6-Rb inhibitor) based on the correlation between SIRT3 and phosphorylated retinoblastoma protein in HCC. Notably, combined treatment with sorafenib and PD0332991 showed an enhancement of the anti-tumor effect in HCC cells. Conclusions: Our data suggest that the modulation of SIRT3 by CDK4/6 inhibition might be useful for HCC therapy together with sorafenib, which, unfortunately, has limited efficacy and whose use is often associated with drug resistance." @default.
- W4251648342 created "2022-05-12" @default.
- W4251648342 creator A5014208708 @default.
- W4251648342 creator A5034732409 @default.
- W4251648342 creator A5040393015 @default.
- W4251648342 creator A5043731787 @default.
- W4251648342 creator A5046164042 @default.
- W4251648342 creator A5047125112 @default.
- W4251648342 creator A5055306078 @default.
- W4251648342 creator A5067285439 @default.
- W4251648342 creator A5073942001 @default.
- W4251648342 creator A5083716771 @default.
- W4251648342 creator A5086452481 @default.
- W4251648342 creator A5090009651 @default.
- W4251648342 date "2020-04-08" @default.
- W4251648342 modified "2023-09-27" @default.
- W4251648342 title "Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells" @default.
- W4251648342 doi "https://doi.org/10.21203/rs.2.16163/v4" @default.
- W4251648342 hasPublicationYear "2020" @default.
- W4251648342 type Work @default.
- W4251648342 citedByCount "0" @default.
- W4251648342 crossrefType "posted-content" @default.
- W4251648342 hasAuthorship W4251648342A5014208708 @default.
- W4251648342 hasAuthorship W4251648342A5034732409 @default.
- W4251648342 hasAuthorship W4251648342A5040393015 @default.
- W4251648342 hasAuthorship W4251648342A5043731787 @default.
- W4251648342 hasAuthorship W4251648342A5046164042 @default.
- W4251648342 hasAuthorship W4251648342A5047125112 @default.
- W4251648342 hasAuthorship W4251648342A5055306078 @default.
- W4251648342 hasAuthorship W4251648342A5067285439 @default.
- W4251648342 hasAuthorship W4251648342A5073942001 @default.
- W4251648342 hasAuthorship W4251648342A5083716771 @default.
- W4251648342 hasAuthorship W4251648342A5086452481 @default.
- W4251648342 hasAuthorship W4251648342A5090009651 @default.
- W4251648342 hasBestOaLocation W42516483421 @default.
- W4251648342 hasConcept C104317684 @default.
- W4251648342 hasConcept C119157956 @default.
- W4251648342 hasConcept C121608353 @default.
- W4251648342 hasConcept C126322002 @default.
- W4251648342 hasConcept C138488276 @default.
- W4251648342 hasConcept C143998085 @default.
- W4251648342 hasConcept C1491633281 @default.
- W4251648342 hasConcept C173396325 @default.
- W4251648342 hasConcept C185592680 @default.
- W4251648342 hasConcept C190283241 @default.
- W4251648342 hasConcept C2776231280 @default.
- W4251648342 hasConcept C2778019345 @default.
- W4251648342 hasConcept C2778264664 @default.
- W4251648342 hasConcept C2778695046 @default.
- W4251648342 hasConcept C2780561631 @default.
- W4251648342 hasConcept C2780646079 @default.
- W4251648342 hasConcept C502942594 @default.
- W4251648342 hasConcept C55493867 @default.
- W4251648342 hasConcept C555283112 @default.
- W4251648342 hasConcept C71924100 @default.
- W4251648342 hasConcept C96232424 @default.
- W4251648342 hasConceptScore W4251648342C104317684 @default.
- W4251648342 hasConceptScore W4251648342C119157956 @default.
- W4251648342 hasConceptScore W4251648342C121608353 @default.
- W4251648342 hasConceptScore W4251648342C126322002 @default.
- W4251648342 hasConceptScore W4251648342C138488276 @default.
- W4251648342 hasConceptScore W4251648342C143998085 @default.
- W4251648342 hasConceptScore W4251648342C1491633281 @default.
- W4251648342 hasConceptScore W4251648342C173396325 @default.
- W4251648342 hasConceptScore W4251648342C185592680 @default.
- W4251648342 hasConceptScore W4251648342C190283241 @default.
- W4251648342 hasConceptScore W4251648342C2776231280 @default.
- W4251648342 hasConceptScore W4251648342C2778019345 @default.
- W4251648342 hasConceptScore W4251648342C2778264664 @default.
- W4251648342 hasConceptScore W4251648342C2778695046 @default.
- W4251648342 hasConceptScore W4251648342C2780561631 @default.
- W4251648342 hasConceptScore W4251648342C2780646079 @default.
- W4251648342 hasConceptScore W4251648342C502942594 @default.
- W4251648342 hasConceptScore W4251648342C55493867 @default.
- W4251648342 hasConceptScore W4251648342C555283112 @default.
- W4251648342 hasConceptScore W4251648342C71924100 @default.
- W4251648342 hasConceptScore W4251648342C96232424 @default.
- W4251648342 hasLocation W42516483421 @default.
- W4251648342 hasLocation W42516483422 @default.
- W4251648342 hasOpenAccess W4251648342 @default.
- W4251648342 hasPrimaryLocation W42516483421 @default.
- W4251648342 hasRelatedWork W11877123 @default.
- W4251648342 hasRelatedWork W12659739 @default.
- W4251648342 hasRelatedWork W14450087 @default.
- W4251648342 hasRelatedWork W17623510 @default.
- W4251648342 hasRelatedWork W18679432 @default.
- W4251648342 hasRelatedWork W3941080 @default.
- W4251648342 hasRelatedWork W6095507 @default.
- W4251648342 hasRelatedWork W7207526 @default.
- W4251648342 hasRelatedWork W7743602 @default.
- W4251648342 hasRelatedWork W828048 @default.
- W4251648342 isParatext "false" @default.
- W4251648342 isRetracted "false" @default.
- W4251648342 workType "article" @default.